logo
‘Mistake' to close health watchdog service, says York manager

‘Mistake' to close health watchdog service, says York manager

Yahoo3 days ago
The manager of Healthwatch York has said government plans to close the watchdog service are a 'mistake' – and called on local and national leaders to rethink the proposals.
Siân Balsom said she is still 'reeling from the news' that the country-wide Healthwatch Network is to close, with the service's role due to be absorbed into local councils and integrated care boards.
But Ms Balsom, writing in The Press, said: 'We're not giving up or giving in just yet.'
She said Healthwatch York started in April 2013 to put people 'at the heart of health and social care'.
And Ms Balsom said York residents can 'keep using and keep relying' on the service until the closure has been finalised.
'We're not giving up or giving in just yet,' says Healthwatch York manager
The Healthwatch network is an independent statutory body which patients can contact to improve NHS standards of care.
But under the government's plans, people will be encouraged to share their feedback via the NHS app instead.
The health secretary, West Streeting, has said 'there are way too many checkers and not enough doers' in the health system.
Responding to questions about the closure of Healthwatch England at the Local Government Association's annual conference in Liverpool, he said: 'I think there are lots of ways in which we have tried to create new bodies to fulfil the failure of other parts of the state to do their job effectively.
'I mean, the revolution we're leading in patient voice will mean we can get rid of some of the intermediaries, and we don't need ventriloquists to speak for patients, patients can speak for ourselves if we're given the opportunity to do it.'
Siân Balsom, manager of Healthwatch York (Image: Supplied) Ms Balsom said she did 'not recognise this description of our work' from the health secretary.
'We ARE doers,' she said. 'We're out and about week in, week out, visiting care homes, local libraries, sitting down with carers groups and disabled people's organisations, community groups and local charities.
'We work closely with our voluntary sector partners to amplify the voices of those least heard in health and care.
'And we choose our priorities based on what you tell us every day – with more than 160 people in York speaking to us in June 2025 alone.'
Ms Balsom said Healthwatch York has 'supported people to navigate complex systems and access the help they need'.
'We've published guides to mental health and wellbeing support and dementia support.
'We've challenged gaps in mental health support both when our mental health hospital was closed at short notice and when we heard ongoing concerns about crisis care.
'We've worked to improve access to GP services.
'We've independently evaluated the changes to the adult ADHD and autism pathway.
'We've taken the concerns of deaf people to the heart of the NHS, helping shape the Accessible Information Standard.'
Ms Balsom described the proposals to close the Healthwatch Network as a 'mistake'.
'We urge local and national leaders to reflect on what will be lost if Healthwatch is stripped of its independence,' she said.
'An effective health and social care system must include a strong, visible, and impartial patient voice, one that listens without fear or favour, and speaks up without interference.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Kidney Function Tests
Kidney Function Tests

Health Line

timean hour ago

  • Health Line

Kidney Function Tests

Key takeaways Kidney function tests are simple blood and urine tests that can identify problems with your kidneys. These tests can estimate your glomerular filtration rate (GFR), which indicates how quickly your kidneys are clearing waste from your body. Your doctor will focus on treating the underlying condition if your tests show early kidney disease. This may include medications, lifestyle changes, or seeing a specialist. Overview of kidney function tests You have two kidneys on either side of your spine that are each approximately the size of a human fist. They're located posterior to your abdomen and below your rib cage. Your kidneys play several vital roles in maintaining your health. One of their most important jobs is to filter waste materials from the blood and expel them from the body as urine. The kidneys also help control the levels of water and various essential minerals in the body. In addition, they're critical to the production of: vitamin D red blood cells hormones that regulate blood pressure If your doctor thinks your kidneys may not be working properly, you may need kidney function tests. These are simple blood and urine tests that can identify problems with your kidneys. You may also need kidney function testing done if you have other conditions that can harm the kidneys, such as diabetes or high blood pressure. They can help doctors monitor these conditions. Symptoms of kidney problems Symptoms that may indicate a problem with your kidneys include: high blood pressure blood in the urine frequent urges to urinate difficulty beginning urination painful urination swelling of the hands and feet due to a buildup of fluids in the body A single symptom may not mean something serious. However, when occurring simultaneously, these symptoms suggest that your kidneys aren't working properly. Kidney function tests can help determine the reason. Types of kidney function tests To test your kidney function, your doctor will order a set of tests that can estimate your glomerular filtration rate (GFR). Your GFR tells your doctor how quickly your kidneys are clearing waste from your body. Urinalysis A urinalysis screens for the presence of protein and blood in the urine. There are many possible reasons for protein in your urine, not all of which are related to disease. Infection increases urine protein, but so does a heavy physical workout. Your doctor may want to repeat this test after a few weeks to see if the results are similar. Your doctor may also ask you to provide a 24-hour urine collection sample. This can help doctors see how fast a waste product called creatinine is clearing from your body. Creatinine is a breakdown product of muscle tissue. Serum creatinine test This blood test examines whether creatinine is building up in your blood. The kidneys usually completely filter creatinine from the blood. A high level of creatinine suggests a kidney problem. According to the National Kidney Foundation (NKF), a creatinine level higher than 1.2 milligrams/deciliter (mg/dL) for women and 1.4 mg/dL for men is a sign of a kidney problem. Blood urea nitrogen (BUN) The blood urea nitrogen (BUN) test also checks for waste products in your blood. BUN tests measure the amount of nitrogen in the blood. Urea nitrogen is a breakdown product of protein. However, not all elevated BUN tests are due to kidney damage. Common medications, including large doses of aspirin and some types of antibiotics, can also increase your BUN. It's important to tell your doctor about any medications or supplements that you take regularly. You may need to stop certain drugs for a few days before the test. A normal BUN level is between 7 and 20 mg/dL. A higher value could suggest several different health problems. Estimated GFR This test estimates how well your kidneys are filtering waste. The test determines the rate by looking at factors, such as: test results, specifically creatinine levels age gender race height weight Any result lower than 60 milliliters/minute/1.73m 2 may be a warning sign of kidney disease. How the tests are performed Kidney function tests usually require a 24-hour urine sample and a blood test. 24-hour urine sample A 24-hour urine sample is a creatinine clearance test. It gives your doctor an idea of how much creatinine your body expels over a single day. On the day that you start the test, urinate into the toilet as you normally would when you wake up. For the rest of the day and night, urinate into a special container provided by your doctor. Keep the container capped and refrigerated during the collection process. Make sure to label the container clearly and to tell other family members why it's in the refrigerator. On the morning of the second day, urinate into the container when you get up. This completes the 24-hour collection process. Follow your doctor's instructions about where to drop the sample off. You may need to return it either to your doctor's office or a laboratory. Blood samples BUN and serum creatinine tests require blood samples taken in a lab or doctor's office. The technician drawing the blood first ties an elastic band around your upper arm. This makes the veins stand out. The technician then cleans the area over the vein. They slip a hollow needle through your skin and into the vein. The blood will flow back into a test tube that will be sent for analysis. You may feel a sharp pinch or prick when the needle enters your arm. The technician will place gauze and a bandage over the puncture site after the test. The area around the puncture may develop a bruise over the next few days. However, you shouldn't feel severe or long-term pain. Treatment of early kidney disease Your doctor will focus on treating the underlying condition if the tests show early kidney disease. Your doctor will prescribe medications to control blood pressure if the tests indicate hypertension. They'll also suggest lifestyle and dietary modifications. If you have diabetes, your doctor may want you to see an endocrinologist. This type of doctor specializes in metabolic diseases and can help ensure that you have the best blood glucose control possible. If there are other causes of your abnormal kidney function tests, such as kidney stones and excessive use of painkillers, your doctor will take appropriate measures to manage those disorders.

One in Five Trainee Doctors Fear Escalating Patient Care
One in Five Trainee Doctors Fear Escalating Patient Care

Medscape

time2 hours ago

  • Medscape

One in Five Trainee Doctors Fear Escalating Patient Care

More than one in five trainee doctors in the UK hesitate to escalate concerns about a patient's condition, according to the latest General Medical Council (GMC) national training survey. This figure rose to nearly one in three among trainees in high-pressure specialties, including surgery, obstetrics and gynaecology, general medicine, and emergency medicine. These groups also reported the highest levels of stress, bullying, and incivility. New for 2024, the GMC asked trainees if they ever felt apprehensive about escalating care to a senior colleague. Among those who reported hesitancy: 4% said they felt this daily or weekly. 5% monthly. 12% less often. Professor Pushpinder Mangat, medical director at the GMC, said: "These findings are extremely concerning. Doctors need to feel comfortable escalating concerns. When they don't, there are potentially serious risks to patient safety." Burnout Risk Still High Burnout levels remain high, with one in five trainees at high risk — double the rate reported in 2019, though slightly down from 2023. Burnout varied significantly by specialty – from 30% in emergency medicine to just 4% in public health. Half of the cohort said that they found their work emotionally exhausting to a high or very high degree. Among trainers, 11% were cat high risk of burnout, and 36% at moderate risk. Despite this, 90% said they enjoyed their role, and 70% rated the support they received as either good or very good. Training Quality Mostly Rated Highly The GMC received responses from 50,637 trainees and 21,289 trainers. Among trainees: 87% rated the quality of their clinical supervision as good or very good. 84% said the quality of their training experience was good or very good. 63% said their posts gave them opportunities to develop their leadership skills. However, concerns persisted: 16% of surgery trainees rated teaching quality as poor or very poor, compared with 3% of GP trainees. 61% were at moderate or high risk of burnout. 39% lacked confidence reporting workplace discrimination. 28% experienced negative behaviour from colleagues. 9% of female and 4% of male trainees reported unwelcome sexual comments or advances. Rota Gaps The survey also found continuing problems due to rota gaps, with 26% saying their training had been affected because these gaps are not being dealt with effectively. The GMC said it is 'vital' that trusts and boards address the issue. The report noted a steady increase over recent years in the proportion of trainees working less than full time, which now involved 30% of female and 15% of male trainees. There was also 'notable variation' between specialties, with 46% of paediatrics and child health trainees training less than full time, compared with just 8% of those in surgery posts. Those rating their workload as heavy or very heavy (42% overall) ranged from 70% in emergency medicine to 19% in public health. Of those who worked less than full-time, or had considered or applied to do so, 66% sought a better work-life balance and 44% cited childcare responsibilities. The GMC called for flexible training models to create a sustainable workforce and safe patient care. It was 'clear that medical education and training needs to adapt', it said.

Hidden health benefits from weight-loss shots revealed
Hidden health benefits from weight-loss shots revealed

Yahoo

time2 hours ago

  • Yahoo

Hidden health benefits from weight-loss shots revealed

Weight-loss injections, including popular drugs like Wegovy and Mounjaro, may offer a protective shield against serious conditions such as dementia and stroke, a new study has indicated. The research also suggests that individuals with type 2 diabetes and obesity who are prescribed these medications could face a reduced risk of premature death. Academics behind the study noted that while the efficacy of GLP agonist drugs – such as semaglutide (found in Wegovy and Ozempic) and tirzepatide (Mounjaro) – in managing weight and blood sugar levels is widely recognised, their wider health benefits have remained less understood. The comprehensive study, conducted by experts in Taiwan, examined data from 60,000 people worldwide, with an average age of 58, all diagnosed with type 2 diabetes and obesity. Roughly half of the participants were given GLP agonist drugs. These medications function by curbing appetite, slowing digestion, reducing the liver's sugar output, and enhancing the body's insulin production when required. The other half used other anti-diabetic medication. During a seven-year follow-up period, researchers found that people given the GLP agonist drugs appeared to have a 37 per cent lower risk of dementia and a 19 per cent reduced risk of stroke. Weight-loss drugs like Wegovy are available on the NHS to obese patients They were also 30 per cent less likely to die during the follow-up period. When researchers looked at the data further, they found even greater benefits in people aged 60 or older, women, and those with a body mass index score of 30 to 40. They found no differences in Parkinson's disease or brain bleeds. The academics said their findings suggest 'potential neuroprotective and cerebrovascular benefits' of the drugs but they called for more studies to confirm the findings. 'These findings suggest that semaglutide and tirzepatide may offer neuroprotective and cerebrovascular benefits beyond glycemic control, potentially improving long-term cognitive and survival outcomes in adults with type 2 diabetes and obesity,' they wrote in the journal JAMA Network Open. Commenting on the study, Professor Tara Spires-Jones, director of the Centre for Discovery Brain Sciences at the University of Edinburgh and group leader in the UK Dementia Research Institute, said: 'This is a very interesting study adding to evidence that GLP1 receptor agonists are associated with a lower risk of dementia in people with type 2 diabetes and obesity. 'This type of study cannot determine whether the drugs reduced disease risk by directly protecting the brain. 'It is highly likely that effectively treating type 2 diabetes and obesity would reduce dementia and stroke risk as they are known risk factors for these conditions. 'Further work is needed including randomised clinical trials to confirm these drugs are protective in people with diabetes and obesity and other trials are needed to determine whether these drugs will be protective in people who do not have type 2 diabetes and obesity.'

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store